SAN FRANCISCO and KIGALI, Rwanda, Feb. 26, 2025 (GLOBE NEWSWIRE) — Bio Usawa, Inc., a pioneering biotechnology company dedicated to developing high-quality, affordable monoclonal antibodies in Africa, appointed Dr. Patrick Lukulay as its Chief Operating Officer. Read here.
Bio Usawa Appoints Dr. Patrick Lukulay as Chief Operating Officer
Posted in Biosimilars, Drug Development.